These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 2495499)
1. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Javitt JC; Canner JK; Sommer A Ophthalmology; 1989 Feb; 96(2):255-64. PubMed ID: 2495499 [TBL] [Abstract][Full Text] [Related]
2. Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. Javitt JC; Canner JK; Frank RG; Steinwachs DM; Sommer A Ophthalmology; 1990 Apr; 97(4):483-94; discussion 494-5. PubMed ID: 2109299 [TBL] [Abstract][Full Text] [Related]
3. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial. Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR; JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920 [TBL] [Abstract][Full Text] [Related]
5. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Javitt JC; Aiello LP; Bassi LJ; Chiang YP; Canner JK Ophthalmology; 1991 Oct; 98(10):1565-73; discussion 1574. PubMed ID: 1961646 [TBL] [Abstract][Full Text] [Related]
6. Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy. Lin J; Chang JS; Smiddy WE Ophthalmology; 2016 Sep; 123(9):1912-8. PubMed ID: 27425822 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of detecting and treating diabetic retinopathy. Javitt JC; Aiello LP Ann Intern Med; 1996 Jan; 124(1 Pt 2):164-9. PubMed ID: 8554212 [TBL] [Abstract][Full Text] [Related]
8. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Javitt JC; Aiello LP; Chiang Y; Ferris FL; Canner JK; Greenfield S Diabetes Care; 1994 Aug; 17(8):909-17. PubMed ID: 7956643 [TBL] [Abstract][Full Text] [Related]
9. Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi. Vetrini D; Kiire CA; Burgess PI; Harding SP; Kayange PC; Kalua K; Msukwa G; Beare NAV; Madan J PLoS One; 2018; 13(1):e0190742. PubMed ID: 29300755 [TBL] [Abstract][Full Text] [Related]
10. Early photocoagulation in patients with either type I or type II diabetes. Ferris F Trans Am Ophthalmol Soc; 1996; 94():505-37. PubMed ID: 8981711 [TBL] [Abstract][Full Text] [Related]
11. Active prevention in diabetic eye disease. A 4-year follow-up. Kristinsson JK; Hauksdóttir H; Stefánsson E; Jónasson F; Gíslason I Acta Ophthalmol Scand; 1997 Jun; 75(3):249-54. PubMed ID: 9253967 [TBL] [Abstract][Full Text] [Related]
12. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis. Kristinsson JK Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048 [TBL] [Abstract][Full Text] [Related]
13. Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy. Crijns H; Casparie AF; Hendrikse F Int J Technol Assess Health Care; 1999; 15(1):198-206. PubMed ID: 10407606 [TBL] [Abstract][Full Text] [Related]
14. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema. Brown GC; Brown MM; Turpcu A; Rajput Y Ophthalmology; 2015 Jul; 122(7):1416-25. PubMed ID: 25935787 [TBL] [Abstract][Full Text] [Related]
15. Clinical applications of cost analysis of diabetic macular edema treatments. Smiddy WE Ophthalmology; 2012 Dec; 119(12):2558-62. PubMed ID: 23062655 [TBL] [Abstract][Full Text] [Related]
16. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review. Swanson M Optometry; 2005 Nov; 76(11):636-46. PubMed ID: 16298316 [TBL] [Abstract][Full Text] [Related]
17. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology; 1991 May; 98(5 Suppl):766-85. PubMed ID: 2062512 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. ; Fong DS; Strauber SF; Aiello LP; Beck RW; Callanan DG; Danis RP; Davis MD; Feman SS; Ferris F; Friedman SM; Garcia CA; Glassman AR; Han DP; Le D; Kollman C; Lauer AK; Recchia FM; Solomon SD Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies. Pochopien M; Beiderbeck A; McEwan P; Zur R; Toumi M; Aballéa S BMC Health Serv Res; 2019 Jan; 19(1):22. PubMed ID: 30626376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]